REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 24
08/03/2016 12:11
- Part 24: For the preceding part double click ID:nRSH4027Rw
result in civil and/or criminal legal proceedings being filed against us,
or in us becoming subject to regulatory sanctions. Regulatory authorities
have wide-ranging administrative powers to deal with any failure to
comply with continuing regulatory oversight and this could affect us,
whether such failure is our own or that of our contractors or external
partners.
Failure of information technology and cybercrime Impact
We are dependent on effective IT systems. These systems support key Any significant disruption to these IT systems, including breaches of data security or cybersecurity, or failure to integrate new and existing IT systems, could harm our reputation and materially adversely affect our financial condition or results of operations.While we have invested heavily in the protection of our data and IT, we may be unable to prevent breakdowns or breaches in our systems that could result in disclosure of confidential information, damage to our reputation, regulatory penalties, financial losses and/or other costs.Significant changes in the business footprint and the implementation of the IT strategy, including the creation and use of captive offshore Global Technology Centres, could lead to temporary loss of capability.The inability to effectively backup and restore data could lead to permanent loss of data that could result in non-compliance with applicable laws and regulations.We and our vendors could be susceptible to third party attacks on our information security systems. Such attacks are of ever-increasing levels of sophistication and are made by groups and individuals with a wide range of motives and expertise, including criminal groups, 'hacktivists' and others. From time to time we experience intrusions, including as a result of computer-related malware.
business functions such as our R&D, manufacturing, supply chain and sales
capabilities and are an important means of safeguarding and communicating
data, including critical or sensitive information, the confidentiality
- More to follow, for following part double click ID:nRSH4027RyRecent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement